Prime Medicine, Inc. (PRME) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.35 | +18.2% |
| 2024 | $-1.65 | +24.3% |
| 2023 | $-2.18 | +48.0% |
| 2022 | $-4.19 | +70.5% |
| 2021 | $-14.19 | -642.9% |
| 2020 | $-1.91 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.35 | +18.2% |
| 2024 | $-1.65 | +24.3% |
| 2023 | $-2.18 | +48.0% |
| 2022 | $-4.19 | +70.5% |
| 2021 | $-14.19 | -642.9% |
| 2020 | $-1.91 | — |